2003

1. Gołąb J. Proteasome inhibitors in the treatment of cancer. Drug Discov Today. 2003 Jul 1;8(13):575.

2. Jakobisiak M, Lasek W, Golab J. Natural mechanisms protecting against cancer. Immunol Lett. 2003 Dec 15;90(2-3):103-22.

3. Jakóbisiak M, Gołąb J. Potential antitumor effects of statins (Review). Int J Oncol. 2003 Oct;23(4):1055-69.

4. Lazarczyk M, Grzela T, Niderla J, Golab J, Korczak-Kowalska G, Oldak M, Skopinski P. Pentoxifylline inhibits leukocyte infiltration and splenocyte cytotoxicity against murine colon adenocarcinoma. Oncol Rep. 2003 Jul-Aug;10(4):839-43.

5. Makowski M, Grzela T, Niderla J, LAzarczyk M, Mroz P, Kopee M, Legat M, Strusinska K, Koziak K, Nowis D, Mrowka P, Wasik M, Jakobisiak M, Golab J. Inhibition of cyclooxygenase-2 indirectly potentiates antitumor effects of photodynamic therapy in mice. Clin Cancer Res. 2003; 9: 5417-5422.
6. Grzela T, Lazarczyk M, Niderla J, Golab J, Lazarczyk MA, Skopinski P. Pentoxifylline promotes development of murine colon adenocarcinoma-derived metastatic tumors in liver. Oncol Rep. 2003; 10: 1805-1809.

7. Orzeszko A, Lasek W, Switaj T, Stoksik M, Kaminska B. Tumor necrosis factor-alpha production-regulating activity of phthalimide derivatives in genetically modified murine melanoma cells B78H1. Farmaco. 2003; 58: 371-376.

8. Kozar K, Kamiński R, Świtaj T, Oldak T, Machaj E, Wysocki PJ, Mackiewicz A, Lasek W, Jakóbisiak M, Gołąb J. Interleukin 12-based immunotherapy improves the antitumor effectiveness of a low-dose 5-Aza-2'-deoxycitidine treatment in L1210 leukemia and B16F10 melanoma models in mice. Clin Cancer Res. 2003; 9: 3124-3133.

9. Gołąb J, Nowis D, Skrzycki M, Czeczot H, Anna Barańczyk-Kuźma A, Wilczyński GM, Makowski M, Mróz P, Kozar K, Kamiński R, Jalili A, Kopeć M, Grzela T, Jakóbisiak M. Antitumor effects of photodynamic therapy are potentiated by 2-methoxyestradiol - a superoxide dismutase inhibitor. J Biol Chem. 2003; 278: 407-414.